Background: Human serum albumin (HSA) is the most abundant protein in human
serum. It has numerous functions, one of which is transport of small hydrophobic molecules,
including drugs, toxins, nutrients, hormones and metabolites. HSA has the ability to interact
with a wide variety of structurally different compounds. This promiscuous, nonspecific affinity
can lead to sudden changes in concentrations caused by displacement, when two or more
compounds compete for binding to the same molecular site.
Objective: It is important to consider drug combinations and their binding to HSA when defining
dosing regimens, as this can directly influence drug’s free, active concentration in
Conclusion: In present paper we review drug interactions with potential for displacement
from HSA, situations in which they are likely to occur and their clinical significance. We also
offer guidelines in designing drugs with decreased binding to HSA.